Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreatic cancer (BRPC): Updated results.

被引：0
|
作者：
Kanji, Zaheer S.
Rocha, Flavio G.
Edwards, Alicia M.
Mandelson, Margaret T.
Lin, Bruce S.
Kozarek, Richard A.
Rose, J. Bart B.
Biehl, Thomas R.
Alseidi, Adnan
Helton, Scott
Picozzi, Vincent J.
机构：
[1] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[2] Virginia Mason Med Ctr, Digest Dis & Canc Inst, Seattle, WA 98101 USA
[3] Virginia Mason Hosp & Med Ctr, Seattle, WA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15771
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15771
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreas cancer (BRPC)
    Rose, J. Bart
    Rocha, Flavio G.
    Lin, Bruce S.
    Alseidi, Adnan
    Biehl, Thomas A.
    Moonka, Ravi
    Ryan, John A.
    Traverso, L. William
    Helton, Scott
    Picozzi, Vincent J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreas cancer (BRPC): Is preoperative chemoradiation (CRT) essential?
    Picozzi, Vincent J.
    Rocha, Flavio G.
    Rose, J. Bart
    Traverso, L. William
    Alseidi, Adnan
    Lin, Bruce S.
    Biehl, Thomas A.
    Ryan, John A.
    Moonka, Ravi
    Helton, Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [3] Toxicity associated with neoadjuvant therapy for borderline resectable pancreatic cancer (BRPC).
    Beg, M. S.
    Olowokure, O. O.
    Ali, S.
    Ahmad, S. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    [J]. FRONTIERS IN ONCOLOGY, 2022, 11
  • [5] Neoadjuvant Therapy (NAT) for Borderline Resectable Pancreatic Cancer (BRPC): Comparison of Histologic Grading Systems of Residual Adenocarcinoma Following Chemotherapy (CT) Alone
    Kim, Sunhee S.
    Ko, Andrew H.
    Nakakura, Eric K.
    Wang, Zhen J.
    Corvera, Carlos U.
    Harris, Hobart W.
    Kirkwood, Kimberly S.
    Hirose, Ryutaro
    Tempero, Margaret A.
    Kim, Grace E.
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 442A - 443A
  • [6] Neoadjuvant Therapy (NAT) for Borderline Resectable Pancreatic Cancer (BRPC): Comparison of Histologic Grading Systems of Residual Adenocarcinoma Following Chemotherapy (CT) Alone
    Kim, Sunhee S.
    Ko, Andrew H.
    Nakakura, Eric K.
    Wang, Zhen J.
    Corvera, Carlos U.
    Harris, Hobart W.
    Kirkwood, Kimberly S.
    Hirose, Ryutaro
    Tempera, Margaret A.
    Kim, Grace E.
    [J]. MODERN PATHOLOGY, 2016, 29 : 442A - 443A
  • [7] Neoadjuvant Chemotherapy Efficacy and Safety in Borderline Resectable Pancreatic Cancer
    He, X.
    Zheng, Y.
    Wang, Jiabao
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 62 - 66
  • [8] Neoadjuvant chemotherapy in borderline resectable pancreatic cancer: A case report
    Palmarocchi, Maria Celeste
    Canger, Ruben Carlo Balzarotti
    Saletti, Piercarlo
    [J]. ONCOLOGY LETTERS, 2017, 13 (06) : 4445 - 4452
  • [9] Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
    Rose, J. Bart
    Rocha, Flavio G.
    Alseidi, Adnan
    Biehl, Thomas
    Moonka, Ravi
    Ryan, John A.
    Lin, Bruce
    Picozzi, Vincent
    Helton, Scott
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (05) : 1530 - 1537
  • [10] Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
    J. Bart Rose
    Flavio G. Rocha
    Adnan Alseidi
    Thomas Biehl
    Ravi Moonka
    John A. Ryan
    Bruce Lin
    Vincent Picozzi
    Scott Helton
    [J]. Annals of Surgical Oncology, 2014, 21 : 1530 - 1537
12345